For childhood cancer survivors, preventable risk factors pose serious threat to heart health
10/15/2013
For childhood cancer survivors, risk factors associated with lifestyle, particularly hypertension, dramatically increase the likelihood of developing serious heart problems as adults, according to a national study led by St. Jude Children's Research Hospital. The findings appear in the current issue of the Journal of Clinical Oncology...
New breast cancer imaging 'detects subtypes and early treatment repsonse'
10/15/2013
Researchers say that a new imaging technique tested on mice is able to identify breast cancer subtypes accurately, as well as detecting early treatment response. This is according to a new study published in the journal Cancer Research...
Compound in red wine, grape skin could help treat cancer
10/14/2013
A new US study suggests that resveratrol, a compound present in grape skin and red wine, could help treat several cancers. Researchers at the University of Missouri (UM) School of Medicine found the compound made melanoma cells more susceptible to radiation treatment...
Red wine, grape skin compound could treat cancers
10/14/2013
A new US study suggests that resveratrol, a compound present in grape skin and red wine, could help treat several cancers. Researchers at the University of Missouri (UM) School of Medicine found the compound made melanoma cells more susceptible to radiation treatment...
Red wine, grape skin compound could treat cancers
10/14/2013
A new US study suggests that resveratrol, a compound present in grape skin and red wine, could help treat several cancers. Researchers at the University of Missouri (UM) School of Medicine found the compound made melanoma cells more susceptible to radiation treatment...
Potential new approach to treating sickle cell disease
10/14/2013
A research team from Dana-Farber/Boston Children's Cancer and Blood Disorders Center and other institutions has discovered a new genetic target for potential therapy of sickle cell disease (SCD). The target, called an enhancer, controls a molecular switch in red blood cells called BCL11A that, in turn, regulates hemoglobin production...
Cancer in EU cost 126 billion Euros in 2009
10/14/2013
The first ever study to evaluate the economic cost of cancer across the 27 countries of the EU has found that the total cost of cancer in the EU in 2009 was 126 billion Euros, with cancer in Germany, France, Italy, and the UK together accounting for just over two-thirds of this cost (83 billion Euros)...
Protection from UV rays provided by circadian rhythms in skin stem cells
10/14/2013
Human skin must cope with UV radiation from the sun and other harmful environmental factors that fluctuate in a circadian manner. A study published by Cell Press in the journal Cell Stem Cell has revealed that human skin stem cells deal with these cyclical threats by carrying out different functions depending on the time of day...
Epstein-Barr virus-associated diseases and cancer
10/14/2013
You might not know it, but most of us are infected with the herpesvirus known as Epstein-Barr virus (EBV). For most of us, the virus will lead at worst to a case of infectious mononucleosis, but sometimes, and especially in some parts of the world, those viruses are found in association with cancer...
Potential new approach to treating sickle cell disease
10/14/2013
A research team from Dana-Farber/Boston Children's Cancer and Blood Disorders Center and other institutions has discovered a new genetic target for potential therapy of sickle cell disease (SCD). The target, called an enhancer, controls a molecular switch in red blood cells called BCL11A that, in turn, regulates hemoglobin production...